Resistant Chronic Spontaneous Urticaria - A Case Series Narrative Review of Treatment Options.

Khan, Sujoy; Chopra, Charu; Mitchell, Alaistair; Nakonechna, Alla; Yong, Patrick; Karim, Mohammed Yousuf

Khan, Sujoy; Chopra, Charu; Mitchell, Alaistair; Nakonechna, Alla; Yong, Patrick; Karim, Mohammed Yousuf.

Affiliation

Khan S; Department of Immunology & Allergy, Queen's Centre, Castle Hill Hospital, Hull University Teaching Hospitals NHS Trust, Cottingham, UK.
Chopra C; Department of Clinical Immunology, Royal Infirmary of Edinburgh, Edinburgh, UK.
Mitchell A; Department of Dermatology, Victoria Hospital, Kirkcaldy, UK.
Nakonechna A; Department of Immunology & Allergy, Queen's Centre, Castle Hill Hospital, Hull University Teaching Hospitals NHS Trust, Cottingham, UK.
Yong P; University of Liverpool, Liverpool, UK.
Karim MY; Department of Immunology & Allergy, Frimley Health NHS Foundation Trust, Frimley, Camberley, UK.

Allergy Rhinol (Providence) ; 13: 21526575221144951, 2022.

Article de En | MEDLINE | ID: mdl-36578314

Mots clés

Chronic spontaneous urticaria; immunosuppressive drugs; omalizumab; resistant urticaria

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Guideline Aspects: Patient_preference Langue: En Journal: Allergy Rhinol (Providence) Année: 2022 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google